Person

Carlos Alban

Director, Solventum

Current S&P 500 boards
1
Current roles
1
Open-market buys
$0
Open-market sales
$35.6M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

  • ABBV
    AbbVie
    Vice Chairman
    2016 or earlier – last filing Nov 2020

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Nov 16, 2020ABBVSale115,830$100.00$11.6M
Jul 7, 2020ABBVSale30,325$100.00$3.0M
Jul 7, 2020ABBVSale23,000$100.00$2.3M
Mar 1, 2018ABBVSale19,169$113.75$2.2M
Mar 1, 2018ABBVSale46,997$114.63$5.4M
Mar 1, 2018ABBVSale14,829$114.43$1.7M
Feb 28, 2018ABBVSale2,579$117.85$304K
Jun 14, 2017ABBVSale45,800$70.00$3.2M
May 4, 2017ABBVSale43,000$67.00$2.9M
May 10, 2016ABBVSale47,438$63.52$3.0M

SEC reporting-owner ID (CIK) 1474632 · all filings on EDGAR